Bacterial Infection Agents In Cancer Patients

Number: 4 December 1, 2013
  • Utku Dilli Dönem
  • Mustafa Yıldırım
  • Nilgün Gür
  • Yeşim Çekin
  • Sevil Göktaş
  • Yasin Şahintürk
  • Mustafa Yıldız
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi Cover
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi
PDF Download
EN TR

Bacterial Infection Agents In Cancer Patients

Abstract

Objective: In this study, the bacterial culture results of specimens obtained from hospitalized patients at the Medical Oncology Services of Antalya Education and Research Hospital during one year period were analyzed for the determination of the distribution of cultured bacterial species.Material and Method: In our study, culture results and the species of bacteria cultured from blood, urine, wound swab, suputum and stool, stool samples taken from the patients during the presence of fever and/or for the suspicion of infection presence were analyzed retrospectively.Results: Growth was observed in 77 samples in total. Among these samples, 38 were blood cultures 9.4% , 21 were urine cultures 27.3% , 9 were abscess cultures 11.7 % , 7 were sputum cultures 9.1% , 2 were stool cultures 2.6% . Among blood samples, coagulase negative staphylococcus was the most frequently seen species with a frequency of 34.2% and the second most frequent species encountered was E.coli being 31.6% . In urine cultures, E.coli was the most frequently isolated species 76.2% . In abscess cultures, S. aureus, E.coli, coagulase negative staphylococcus were detected in equal amounts. In sputum cultures, E.coli and E.faecalis were most frequently detected.Conclusion: Bacterial infections were widely observed in patients with suppressed immune systems. We think that knowing the frequency of bacterial species grown in culture of specimens obtained from these patients may be an important factor for the success of the empirical treatment

Keywords

References

  1. Smiley S, Almyroudis N, Segal BH. Epidemiology And Management Of Opportunistic Infections In Immunocompromised Patients With Cancer. Abstr. Hematol Oncol 2005;8:20-30.
  2. Schilling MB, Parks C, Deeter RG. Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study. Exp Ther Med 2011;2:859-866.
  3. de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F; ESMO Guidelines Working Group. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2010;21:252-6.
  4. Poon LM, Jin J, Chee YL, Ding Y, Lee YM, Chng WJ, et al. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Singapore Med J 2012;53:720-5.
  5. Özer S, Oltan N, Salepçi T, Gençer S. Febril nötropenik olguların irdelenmesi. KLİMİK Dergisi, 1999;12: 32-5.
  6. Wilke A, Dinçol D, Demirkazık A, et al. Kanser hastalarında infeksiyon ataklarının, infeksiyon düşündüren dönemlerin ve mikrobiyal kolonizasyonların değerlendirilmesi. Türk Hematoloji Onkoloji Dergisi, 1992;2:162-8.
  7. Onul M, Bitirgen M. Lösemi ve Lenfomalı Hastalarda Boğazın Aerob Bakteriyel ve Fungal Florası. Türkiye Klinikleri J Med Res 1985;3:145-50.
  8. Hasçelik G, A Günalp: Lenfomalı hastalarda görülen bakteriyel enfeksiyonlar. Tıp Bilimleri Araşt Dergisi 1983;1:1-5.

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Utku Dilli Dönem

Mustafa Yıldırım

Nilgün Gür

Yeşim Çekin

Sevil Göktaş

Yasin Şahintürk

Mustafa Yıldız

Publication Date

December 1, 2013

Submission Date

-

Acceptance Date

-

Published in Issue

Year 1970 Number: 4

IZ

https://izlik.org/JA34YB89UD

Cite

RIS / Bibtex
EndNote
Dönem UD, Yıldırım M, Gür N, Çekin Y, Göktaş S, Şahintürk Y, Yıldız M (December 1, 2013) Kanser Hastalarında Bakteriyel Enfeksiyon Etkenleri. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 4 185–188.